BrandonHardestyMD
Hematology • Indianapolis, INHemophilia & Bleeding Disorder, Sickle Cell & Other Anemias
Adult Hematologist
Dr. Hardesty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8326 Naab Road
Indianapolis, IN 46260Phone+1 317-871-0000Fax+1 317-871-0010- Is this information wrong?
Summary
- Dr. Brandon Hardesty is a hematologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Ascension St. Vincent Indianapolis Hospital, Indiana University Health North Hospital, Ascension St. Vincent Heart Center, Seton Specialty Hospital of Indianapolis, Indiana University Health University Hospital, Ascension St. Vincent Carmel Hospital, St. Vincent Hospital and Health Care Services, Inc, and IU Health Methodist Hospital. He received his medical degree from Ohio State University College of Medicine and has been in practice 11 years. He specializes in hemophilia & bleeding disorder and sickle cell & other anemias and is experienced in sickle-cell anemia, ligneous conjunctivitis, bleeding disorders, and plasminogen deficiency.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013- Indiana University School of MedicineResidency, Internal Medicine, 2006 - 2009
Ohio State University College of MedicineClass of 2006
Certifications & Licensure
IN State Medical License 2008 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top Doctor Castle Connolly, 2019-2023
Clinical Trials
- Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A Start of enrollment: 2015 Dec 30
- A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia Start of enrollment: 2016 May 04
- Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE) Start of enrollment: 2016 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sens...Wei Li, Andrew Q Pucka, Candice Debats, Brandon Reyes, Fahim Syed, Andrew R O'Brien, Rakesh Mehta, Naveen Manchanda, Seethal A Jacob, Brandon M Hardesty, Anne Greist, ...> ;Medrxiv. 2023 Sep 5
- Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study.Brandon Hardesty, Ara Metjian, Thomas L Ortel, Jie Chen, Kayode Badejo, Alice Ma, Adam Cuker, Anita Rajasekhar, Kenneth D Friedman, Maissaa Janbain, Tarantino, M.> ;Haemophilia. 2023 Sep 1
- Increasing Visibility of Sickle Cell Disease in Indiana: Establishing Baseline Prevalence Using Integrated Data From Multiple Sources.Amanda I Okolo, Seethal A Jacob, Brian E Dixon, Nimish R Valvi, Brandon M Hardesty, Janson, I.> ;Public Health Reports. 2023 May 26
- Join now to see all
Abstracts/Posters
- Cardiovascular Disease Prevention in Persons with HemophiliaBrandon Hardesty, Joel Bowen, Suman Sood, Craig Kessler, MaissaaJanbain, Miguel Escobar, Doris Quon, American Society of Hematology, New Orleans, LA, 12/12/2022
- Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with HypoplasminogenemiaHardesty, BM; Plum, S; Thibaudeau, K; Lee, M; Thukral, N; Shapiro, AD, American Society of Hematology, Orlando, FL, 12/7/2015
- Lineage-specific Chimerism Analysis of Post-infusion, Pre-engraftment Sorted Peripheral Blood Cells after Minimal Intensity AllotransplantationHardesty, Brandon M; Pike, Jason; Al Baghdadi, Tareq; Srivastava, Shivani; Schwartz, Jennifer E; Robertson, Michael J; Rojas, Luis A; Wood, Lisa L; Abonour, Rafat; Far..., Federation of Clinical Immunology Societies, Vancouver, Canada
- Join now to see all
Lectures
- Introduction to Hemophilia Gene TherapyVirtual - 9/2023
- Surgical Prophylaxis in vWD: Maintaining the BalanceWorld Federation of Hemophilia Orlando, FL - 7/25/2016
- Emergency Management of the Bleeding PatientMemorial Hospital of South Bend - 4/29/2015
- Join now to see all
Other
- Emergency Management of the Bleeding PatientBrandon M. Hardesty, MD
http://www.ihtc.org/cme/embp/
CME Module - 12/18/2015
Authored Content
- Plasminogen Deficiency6/1/2018
Press Mentions
Pharmaceutical companies seek FDA approval for new sickle cell cure via gene therapyOctober 31st, 2023
Advocates Raising Awareness of Sickle Cell DiseaseFebruary 10th, 2024
Grant Support
- Indiana Sickle Cell Data Collection ProgramCenters for Disease Control2023–2028
- Sickle Cell Treatment Demonstration Program Regional CollaborativeDepartment of Health and Human Services, Health Resources & Services Administration2014–2025
- Prospective Management of Cardiovascular DiseaseBayer Healthcare Pharmaceuticals, Inc2020–2023
Professional Memberships
- Member
- Member
- International Society on Thrombosis and HaemostasisMember
- World Federation of HemophiliaMember
Hospital Affiliations
Ascension St. Vincent Indianapolis HospitalIndianapolis, Indiana
Indiana University Health North HospitalCarmel, Indiana- Ascension St. Vincent Heart CenterIndianapolis, Indiana
- Seton Specialty Hospital of IndianapolisIndianapolis, Indiana
Indiana University Health University HospitalIndianapolis, Indiana- Ascension St. Vincent Carmel HospitalCarmel, Indiana
- St. Vincent Hospital and Health Care Services, IncIndianapolis, Indiana
IU Health Methodist HospitalIndianapolis, Indiana
Industry Relationships
- Travel and Research support, Global Blood TherapeuticsDisclosure: All fees and honoraria are voluntarily donated to the Indiana Hemophilia and Thrombosis Center.2017 - 2017
- Research, Travel, Advisory Board, and Speaker, Shire Pharmaceuticals (formerly Baxalta)Disclosure: All fees are voluntarily donated to the Indiana Hemophilia and Thrombosis Center.2015 - 2017
- Consultant, Travel, and Advisory Board, Novo NordiskDisclosure: All fees are voluntarily donated to the Indiana Hemophilia and Thrombosis Center2014 - 2017
- Consultant, OctapharmaDisclosure: All fees are voluntarily donated to the Indiana Hemophilia and Thrombosis Center.2016 - 2016
- Research Funding, ProMetic Biotherapeutics2015 - 2016
- Consultant, BiogenDisclosure: All fees are voluntarily donated to the Indiana Hemophilia and Thrombosis Center.2015 - 2015
External Links
- LinkedInhttp://www.linkedin.com/pub/brandon-hardesty-md/a0/a70/316/
- IHTChttp://www.ihtc.org
- ResearchGatehttps://www.researchgate.net/profile/Brandon_Hardesty
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
